RxDoctor Payments Data

John Bosworth, MD

Otolaryngology · Rockville, MDNPI 1750339743

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,380 of the $4,388 with a category attached, or 77.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.

$4,388in general payments, 2019–2025

Across 109 payments — averaging $40.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurent Medical Limited$930
  • Aerin Medical Inc.$878
  • GSK$478
  • Acclarent, Inc$384
  • Sanofi$372
  • Optinose US, Inc.$369
  • plus $979 from 14 others

What the payments were for

  • Consulting fees$1,00823%
  • Food & beverage$3,38077%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,388 in reported general payments places this provider in the 80th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$229,936
Medicare patients
762
Services billed
2,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone132$12,021
Ipratropium Bromide127$4,681
Fluticasone Propionate206$3,810
Mometasone Furoate15$1,292
Pantoprazole Sodium117$1,231
Azelastine Hcl30$1,223
Famotidine37$382
CefuroximeCefuroxime Axetil16$238
Prednisone45$167

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →